Roche’s $1.5 Billion Notes Offering


Simpson Thacher represented Barclays Capital Inc., Citigroup Global Markets Inc. and Santander Investment Securities Inc. as joint bookrunners for an offering by Roche Holdings, Inc. of $850 million 2.375% Notes due 2027 and $650 million 1.75% Notes due 2022, which are guaranteed by Roche Holding Ltd.

The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933.

The Roche Group is a leading international research-focused healthcare group which is active in more than 100 countries. Based on 2015 sales, the Roche Group was among the world’s largest producers of pharmaceuticals and was the world’s leading supplier of in vitro diagnostics.

The Simpson Thacher team for the offering included Mark Brod (Picture), Paula Querol and Anna Pollak (Capital Markets); Amber Harezlak (Intellectual Property); Jon Cantor and Michelle Goldring (Tax); Michael Isby (Environmental); and Jennie Getsin (Blue Sky).

Involved fees earner: Mark Brod – Simpson Thacher & Bartlett; Paula Querol – Simpson Thacher & Bartlett; Anna Pollak – Simpson Thacher & Bartlett; Amber Harezlak – Simpson Thacher & Bartlett; Jonathan Cantor – Simpson Thacher & Bartlett; Michelle Goldring – Simpson Thacher & Bartlett; Michael Isby – Simpson Thacher & Bartlett; Jennie Getsin – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Barclays Capital; Citigroup Global Markets Ltd; Banco Santander Sa;